Mobile Health Technology for Atrial Fibrillation
(mTECH Afib Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
The overall objective of this proposal is to evaluate the effect on quality of life of a comprehensive digital atrial fibrillation (AFib) management tool that will empower patients to a) take an active role in learning about AFib management options, starting and adhering to evidence-based therapies and lifestyle changes and b) to guide the patients during AFib episodes which are associated with anxiety and impairment in quality of life.Researchers plan to evaluate the effectiveness of this novel digital toolkit in improving quality of life and decreasing AFib burden in a randomized clinical trial (RCT). A pilot study assessing feasibility and retention of the intervention was previously conducted (NCT05400837)
Who Is on the Research Team?
David Spragg, MD
Principal Investigator
Johns Hopkins University
Are You a Good Fit for This Trial?
This trial is for adults aged 18 or older who have been diagnosed with paroxysmal (AFib lasting less than 7 days) or persistent atrial fibrillation (lasting 7 days or longer), and have a BMI of 27.0 or higher.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants use a comprehensive digital atrial fibrillation management tool to learn about AFib management options and adhere to therapies and lifestyle changes
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Corrie Virtual Atrial Fibrillation Management Program
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
Apple Inc.
Industry Sponsor
PhRMA Foundation
Collaborator
Itamar-Medical, Israel
Industry Sponsor
Pharmaceutical Research & Manufacturers Of America Foundation
Collaborator